“Our mission is to increase and enhance lives by making genomics a foundational a part of everybody’s well being and wellness journey.” - Alexander Bisignano.
Alexander Bisignano’s early ardour for science and biology led him on an thrilling journey to changing into the CEO of Phosphorus, an organization with a ground-breaking strategy to medical-grade genetic testing.
Not too long ago, Alexander and his co-founder launched GeneCompass, a preventative consumer-genetic take a look at, powered by Subsequent Era Sequencing (NGS) expertise to study greater than 400 genes. The take a look at leverages DNA Genotek’s Oragene•Dx at-home, self-collection saliva units to accumulate high-quality DNA samples so as to detect greater than 200 well being dangers, over 200 genetic drug interactions, and uncover insights into greater than 40 wellness attributes.
Alexander’s thought finds its origins within the rising world reputation of genetic testing, amongst healthcare professionals, lecturers, researchers, and these days shoppers. Advances in genetic-sequencing applied sciences have paved the way in which for tailored diagnostic in addition to therapeutic well being companies; and have improved sufferers’ and people’ well being outcomes via personalised well being.
Alexander and his co-founder wished to ship a genetic-testing service that focuses totally on offering the expertise, infrastructure, and experience to drive healthcare care initiatives. They established a CLIA-certified* laboratory, in New Jersey, that permits sufferers and their physicians to make the most of genetic testing for diagnostic and therapeutic functions.
In the newest episode of our Podcast, Molecules, Microbes, and Multiomics, we invited Alexander Bisignano to inform us extra about his firm’s utility of genetic testing and to share what’s in retailer for them sooner or later.
We hope you benefit from the dialog!
*CLIA stands for Medical Laboratory Enchancment Amendments
 |
 |
Be taught extra about Phosphorus’ Genomic Platform
